Greg Cook is the senior director of access, policy and advocacy at Bristol Myers Squibb Australia. In a Q&A with BioPharmaDispathch, he discusses the 'access' challenge and the need for the health technology assessment review to focus on achieving the 'North Star' for patients.
Faster patient access must be the 'North Star' for HTA review
March 22, 2023 Latest NewsBioPharmaBioPharmaDispatch Executive
Latest Video
New Stories
-
Todd Stephenson confirmed on ACT list for New Zealand election
September 14, 2026 - - Latest News -
Scandal-hit KPMG still holds $37 million in health department work
September 14, 2026 - - Latest News -
Canberra details tax changes with limited concessions for some innovators
September 14, 2026 - - Latest News -
The 'Dispatched' Week in Review Podcast - 11 September
September 11, 2026 - - Podcast -
Rare genetic motor neurone disease treatment finally reaches Australian patients
September 11, 2026 - - Latest News -
NSW pharmacists to deliver all childhood vaccines and treat more conditions under reforms
September 11, 2026 - - Latest News -
AI Health Summit 2026
September 10, 2026 - - Summit
